Mitch Collett
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
15
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mitch Collett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CCEP Coca-Cola Europacific Partners | Maintains: Buy | $78 → $90 | $75.60 | +19.05% | 5 | Sep 9, 2024 | |
| KPTI Karyopharm Therapeutics | Maintains: Outperform | $8 → $5 | $0.90 | +453.59% | 2 | Aug 7, 2024 | |
| BUD Anheuser-Busch InBev | Upgrades: Buy | n/a | $59.30 | - | 1 | Jun 22, 2023 | |
| DEO Diageo | Downgrades: Sell | n/a | $124.21 | - | 5 | Jun 29, 2022 | |
| UL Unilever | Downgrades: Hold | n/a | $61.32 | - | 2 | Sep 16, 2021 |
Coca-Cola Europacific Partners
Sep 9, 2024
Maintains: Buy
Price Target: $78 → $90
Current: $75.60
Upside: +19.05%
Karyopharm Therapeutics
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $5
Current: $0.90
Upside: +453.59%
Anheuser-Busch InBev
Jun 22, 2023
Upgrades: Buy
Price Target: n/a
Current: $59.30
Upside: -
Diageo
Jun 29, 2022
Downgrades: Sell
Price Target: n/a
Current: $124.21
Upside: -
Unilever
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $61.32
Upside: -